187 related articles for article (PubMed ID: 36196489)
1. Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers.
Hemminki K; Sundquist K; Sundquist J; Försti A; Liska V; Hemminki A; Li X
Int J Cancer; 2023 Mar; 152(6):1107-1114. PubMed ID: 36196489
[TBL] [Abstract][Full Text] [Related]
2. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
Koea J; Phillips A; Lawes C; Rodgers M; Windsor J; McCall J
ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
[TBL] [Abstract][Full Text] [Related]
3. Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers.
Hemminki K; Sundquist K; Sundquist J; Försti A; Liska V; Hemminki A; Li X
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370702
[TBL] [Abstract][Full Text] [Related]
4. Cholecystectomy reduces the risk of cholangiocarcinoma in patients with complicated gallstones, but has negligible effect on hepatocellular carcinoma.
Ahn HS; Kim HJ; Kang TU; Park SM
J Gastroenterol Hepatol; 2022 Apr; 37(4):669-677. PubMed ID: 34907591
[TBL] [Abstract][Full Text] [Related]
5. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
Tischoff I; Tannapfel A
Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
[TBL] [Abstract][Full Text] [Related]
6. Hepatobiliary cancers, version 2.2014.
Benson AB; D'Angelica MI; Abrams TA; Are C; Bloomston PM; Chang DT; Clary BM; Covey AM; Ensminger WD; Iyer R; Kelley RK; Linehan D; Malafa MP; Meranze SG; Park JO; Pawlik T; Posey JA; Scaife C; Schefter T; Sigurdson ER; Tian GG; Vauthey JN; Venook AP; Yen Y; Zhu AX; Hoffmann KG; McMillian NR; Sundar H
J Natl Compr Canc Netw; 2014 Aug; 12(8):1152-82. PubMed ID: 25099447
[TBL] [Abstract][Full Text] [Related]
7. Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies.
McGee EE; Jackson SS; Petrick JL; Van Dyke AL; Adami HO; Albanes D; Andreotti G; Beane-Freeman LE; Berrington de Gonzalez A; Buring JE; Chan AT; Chen Y; Fraser GE; Freedman ND; Gao YT; Gapstur SM; Gaziano JM; Giles GG; Grant EJ; Grodstein F; Hartge P; Jenab M; Kitahara CM; Knutsen SF; Koh WP; Larsson SC; Lee IM; Liao LM; Luo J; Milne RL; Monroe KR; Neuhouser ML; O'Brien KM; Peters U; Poynter JN; Purdue MP; Robien K; Sandler DP; Sawada N; Schairer C; Sesso HD; Simon TG; Sinha R; Stolzenberg-Solomon R; Tsugane S; Wang R; Weiderpass E; Weinstein SJ; White E; Wolk A; Yuan JM; Zeleniuch-Jacquotte A; Zhang X; Zhu B; McGlynn KA; Campbell PT; Koshiol J
J Natl Cancer Inst; 2019 Dec; 111(12):1263-1278. PubMed ID: 31127946
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.
Rustagi T; Dasanu CA
J Gastrointest Cancer; 2012 Jun; 43(2):137-47. PubMed ID: 21597894
[TBL] [Abstract][Full Text] [Related]
9. [Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].
Grundmann RT; Meyer F
Zentralbl Chir; 2014 Apr; 139(2):184-92. PubMed ID: 24777600
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden.
Hemminki K; Sundquist K; Sundquist J; Försti A; Liska V; Hemminki A; Li X
Cancer; 2023 Jan; ():. PubMed ID: 36715017
[TBL] [Abstract][Full Text] [Related]
11. Association between metabolic syndrome and hepatobiliary cancers: A case-control study.
Menon S; Mathew R
Indian J Gastroenterol; 2019 Feb; 38(1):61-68. PubMed ID: 30628006
[TBL] [Abstract][Full Text] [Related]
12. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics.
Ehlken H; Schramm C
Dig Dis; 2013; 31(1):118-25. PubMed ID: 23797133
[TBL] [Abstract][Full Text] [Related]
13. [Epidemiology of primary and secondary liver cancers].
Jepsen P; Kissmeyer-Nielsen P
Ugeskr Laeger; 2008 Apr; 170(16):1323-5. PubMed ID: 18433588
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: A systematic review and meta-analysis.
Clements O; Eliahoo J; Kim JU; Taylor-Robinson SD; Khan SA
J Hepatol; 2020 Jan; 72(1):95-103. PubMed ID: 31536748
[TBL] [Abstract][Full Text] [Related]
15. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
Plentz RR; Malek NP
Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
[TBL] [Abstract][Full Text] [Related]
16. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.
Henson DE; Schwartz AM; Nsouli H; Albores-Saavedra J
Arch Pathol Lab Med; 2009 Jan; 133(1):67-71. PubMed ID: 19123739
[TBL] [Abstract][Full Text] [Related]
17. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
18. Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma.
Patt YZ; Hassan MM; Aguayo A; Nooka AK; Lozano RD; Curley SA; Vauthey JN; Ellis LM; Schnirer II; Wolff RA; Charnsangavej C; Brown TD
Cancer; 2004 Aug; 101(3):578-86. PubMed ID: 15274071
[TBL] [Abstract][Full Text] [Related]
19. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database.
Welzel TM; Graubard BI; Zeuzem S; El-Serag HB; Davila JA; McGlynn KA
Hepatology; 2011 Aug; 54(2):463-71. PubMed ID: 21538440
[TBL] [Abstract][Full Text] [Related]
20. Association of nonalcoholic fatty liver disease and liver cancer.
Schulz PO; Ferreira FG; Nascimento Mde F; Vieira A; Ribeiro MA; David AI; Szutan LA
World J Gastroenterol; 2015 Jan; 21(3):913-8. PubMed ID: 25624725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
